AnPac Bio Reports 49.1% Decrease in Net Loss in First Quarter of Fiscal 2022
bdtonline.com
news
2022-05-31 21:02:52

PHILADELPHIA, May 31, 2022 (GLOBE NEWSWIRE) -- AnPac Bio-Medical Science Co., Ltd. ('AnPac Bio,' the 'Company' or 'we') (NASDAQ: ANPC), a biotechnology company with operations in China and the United States, announced today its unaudited financial results for the first quarter ended March 31, 2022. The Company's financial statements and related financial information for the quarter ended March 31, 2022 are unaudited and have not been reviewed by the Company's independent registered accountant. These financial results could differ materially if they were reviewed by the Company's independent registered accountant.
